drug
as of 2026-07-01Deep brain stimulation
Deep Brain Stimulationdeep brain stimulation
MeSH D046690
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Centre for Addiction and Mental Health
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DEVICE
Indications
Investigational (via trials)
Autistic DisorderSchizophrenia; Negative TypeSchizophreniaSchizo Affective DisorderSchizophrenia DisordersObsessive-Compulsive DisorderAnorexia NervosaMental DisordersSchizophrenia, Treatment-ResistantGamblingNeurologic ManifestationsPsychotic DisordersDeep Brain StimulationRefractory SchizophreniaBrain DiseasesSigns and Symptoms
Trials
4
SEEG-Guided DBS for Schizophrenia
NCT07671261—Recruiting
Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory Schizophrenia
NCT07369401—Not Yet Recruiting
Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
NCT06112067—Recruiting
Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia
NCT01725334Phase 1Withdrawn
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication
KOL
Zhen Wang, MD,PhD
personKOL score —
Zafiris J Daskalakis, MD, PhD
personKOL score —